The global pharmaceutical spray drying market size is calculated at USD 2.56 billion in 2025 and is forecasted to reach around USD 4.99 billion by 2034, accelerating at a CAGR of 7.68% from 2025 to 2034. The North America market size surpassed USD 885.36 million in 2024 and is expanding at a CAGR of 7.91% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Pharmaceutical Spray Drying Market Revenue and Volume, by Product Type
7.1.1. Spray Dried Formulations
7.1.1.1. Market Revenue and Volume Forecast
7.1.2. Spray Drying Equipment
7.1.2.1. Market Revenue and Volume Forecast
8.1. Pharmaceutical Spray Drying Market Revenue and Volume, by Drug Type
8.1.1. Small Molecule Drugs
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Biologics
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Monoclonal Antibodies
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Highly Potent APIs (HPAPIs)
8.1.4.1. Market Revenue and Volume Forecast
9.1. Pharmaceutical Spray Drying Market Revenue and Volume, by Formulation Type
9.1.1. Powder
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Granules
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Microparticles
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Nanoparticles
9.1.4.1. Market Revenue and Volume Forecast
10.1. Pharmaceutical Spray Drying Market Revenue and Volume, by Application Type
10.1.1. Pulmonary Drug Delivery
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Oral Drug Delivery
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Nasal Drug Delivery
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Parenteral Drug Delivery
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Topical Drug Delivery
10.1.5.1. Market Revenue and Volume Forecast
11.1. Pharmaceutical Spray Drying Market Revenue and Volume, by Operation Mode
11.1.1. Batch Mode
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Continuous Mode
11.1.2.1. Market Revenue and Volume Forecast
12.1. Pharmaceutical Spray Drying Market Revenue and Volume, by Scale of Operation
12.1.1. R&D/Laboratory Use
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Pilot Scale Production
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Commercial/Industrial Production
12.1.3.1. Market Revenue and Volume Forecast
13.1. Pharmaceutical Spray Drying Market Revenue and Volume, by End-User
13.1.1. Pharmaceutical Companies
13.1.1.1. Market Revenue and Volume Forecast
13.1.2. Biopharmaceutical Companies
13.1.2.1. Market Revenue and Volume Forecast
13.1.3. Contract Development & Manufacturing Organizations (CDMOs)
13.1.3.1. Market Revenue and Volume Forecast
13.1.4. Academic & Research Institutes
13.1.4.1. Market Revenue and Volume Forecast
14.1. Pharmaceutical Spray Drying Market Revenue and Volume, by Technique/Technology Used
14.1.1. Closed Loop Spray Drying
14.1.1.1. Market Revenue and Volume Forecast
14.1.2. Open Loop Spray Drying
14.1.2.1. Market Revenue and Volume Forecast
14.1.3. Nano Spray Drying
14.1.3.1. Market Revenue and Volume Forecast
14.1.4. Multi-Fluid Nozzle Spray Drying
14.1.4.1. Market Revenue and Volume Forecast
14.1.5. Two-Fluid Nozzle Spray Drying
14.1.5.1. Market Revenue and Volume Forecast
15.1. North America
15.1.1. Market Revenue and Volume Forecast, by Product Type
15.1.2. Market Revenue and Volume Forecast, by Drug Type
15.1.3. Market Revenue and Volume Forecast, by Formulation Type
15.1.4. Market Revenue and Volume Forecast, by Application Type
15.1.5. Market Revenue and Volume Forecast, by Operation Mode
15.1.6. Market Revenue and Volume Forecast, by Scale of Operation
15.1.7. Market Revenue and Volume Forecast, by End-User
15.1.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.1.9. U.S.
15.1.9.1. Market Revenue and Volume Forecast, by Product Type
15.1.9.2. Market Revenue and Volume Forecast, by Drug Type
15.1.9.3. Market Revenue and Volume Forecast, by Formulation Type
15.1.9.4. Market Revenue and Volume Forecast, by Application Type
15.1.9.5. Market Revenue and Volume Forecast, by Operation Mode
15.1.9.6. Market Revenue and Volume Forecast, by Scale of Operation
15.1.9.7. Market Revenue and Volume Forecast, by End-User
15.1.9.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.1.10. Rest of North America
15.1.10.1. Market Revenue and Volume Forecast, by Product Type
15.1.10.2. Market Revenue and Volume Forecast, by Drug Type
15.1.10.3. Market Revenue and Volume Forecast, by Formulation Type
15.1.10.4. Market Revenue and Volume Forecast, by Application Type
15.1.10.5. Market Revenue and Volume Forecast, by Operation Mode
15.1.10.6. Market Revenue and Volume Forecast, by Scale of Operation
15.1.10.7. Market Revenue and Volume Forecast, by End-User
15.1.10.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.2. Europe
15.2.1. Market Revenue and Volume Forecast, by Product Type
15.2.2. Market Revenue and Volume Forecast, by Drug Type
15.2.3. Market Revenue and Volume Forecast, by Formulation Type
15.2.4. Market Revenue and Volume Forecast, by Application Type
15.2.5. Market Revenue and Volume Forecast, by Operation Mode
15.2.6. Market Revenue and Volume Forecast, by Scale of Operation
15.2.7. Market Revenue and Volume Forecast, by End-User
15.2.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.2.9. UK
15.2.9.1. Market Revenue and Volume Forecast, by Product Type
15.2.9.2. Market Revenue and Volume Forecast, by Drug Type
15.2.9.3. Market Revenue and Volume Forecast, by Formulation Type
15.2.9.4. Market Revenue and Volume Forecast, by Application Type
15.2.9.5. Market Revenue and Volume Forecast, by Operation Mode
15.2.9.6. Market Revenue and Volume Forecast, by Scale of Operation
15.2.9.7. Market Revenue and Volume Forecast, by End-User
15.2.9.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.2.10. Germany
15.2.10.1. Market Revenue and Volume Forecast, by Product Type
15.2.10.2. Market Revenue and Volume Forecast, by Drug Type
15.2.10.3. Market Revenue and Volume Forecast, by Formulation Type
15.2.10.4. Market Revenue and Volume Forecast, by Application Type
15.2.10.5. Market Revenue and Volume Forecast, by Operation Mode
15.2.10.6. Market Revenue and Volume Forecast, by Scale of Operation
15.2.10.7. Market Revenue and Volume Forecast, by End-User
15.2.10.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.2.11. France
15.2.11.1. Market Revenue and Volume Forecast, by Product Type
15.2.11.2. Market Revenue and Volume Forecast, by Drug Type
15.2.11.3. Market Revenue and Volume Forecast, by Formulation Type
15.2.11.4. Market Revenue and Volume Forecast, by Application Type
15.2.11.5. Market Revenue and Volume Forecast, by Operation Mode
15.2.11.6. Market Revenue and Volume Forecast, by Scale of Operation
15.2.11.7. Market Revenue and Volume Forecast, by Technique/Technology Used
15.2.11.8. Market Revenue and Volume Forecast, by End-User
15.2.12. Rest of Europe
15.2.12.1. Market Revenue and Volume Forecast, by Product Type
15.2.12.2. Market Revenue and Volume Forecast, by Drug Type
15.2.12.3. Market Revenue and Volume Forecast, by Formulation Type
15.2.12.4. Market Revenue and Volume Forecast, by Application Type
15.2.12.5. Market Revenue and Volume Forecast, by Operation Mode
15.2.12.6. Market Revenue and Volume Forecast, by Scale of Operation
15.2.12.7. Market Revenue and Volume Forecast, by End-User
15.2.12.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.3. APAC
15.3.1. Market Revenue and Volume Forecast, by Product Type
15.3.2. Market Revenue and Volume Forecast, by Drug Type
15.3.3. Market Revenue and Volume Forecast, by Formulation Type
15.3.4. Market Revenue and Volume Forecast, by Application Type
15.3.5. Market Revenue and Volume Forecast, by Operation Mode
15.3.6. Market Revenue and Volume Forecast, by Scale of Operation
15.3.7. Market Revenue and Volume Forecast, by End-User
15.3.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.3.9. India
15.3.9.1. Market Revenue and Volume Forecast, by Product Type
15.3.9.2. Market Revenue and Volume Forecast, by Drug Type
15.3.9.3. Market Revenue and Volume Forecast, by Formulation Type
15.3.9.4. Market Revenue and Volume Forecast, by Application Type
15.3.9.5. Market Revenue and Volume Forecast, by Operation Mode
15.3.9.6. Market Revenue and Volume Forecast, by Scale of Operation
15.3.9.7. Market Revenue and Volume Forecast, by End-User
15.3.9.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.3.10. China
15.3.10.1. Market Revenue and Volume Forecast, by Product Type
15.3.10.2. Market Revenue and Volume Forecast, by Drug Type
15.3.10.3. Market Revenue and Volume Forecast, by Formulation Type
15.3.10.4. Market Revenue and Volume Forecast, by Application Type
15.3.10.5. Market Revenue and Volume Forecast, by Operation Mode
15.3.10.6. Market Revenue and Volume Forecast, by Scale of Operation
15.3.10.7. Market Revenue and Volume Forecast, by End-User
15.3.10.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.3.11. Japan
15.3.11.1. Market Revenue and Volume Forecast, by Product Type
15.3.11.2. Market Revenue and Volume Forecast, by Drug Type
15.3.11.3. Market Revenue and Volume Forecast, by Formulation Type
15.3.11.4. Market Revenue and Volume Forecast, by Application Type
15.3.11.5. Market Revenue and Volume Forecast, by Operation Mode
15.3.11.6. Market Revenue and Volume Forecast, by Scale of Operation
15.3.11.7. Market Revenue and Volume Forecast, by End-User
15.3.11.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.3.12. Rest of APAC
15.3.12.1. Market Revenue and Volume Forecast, by Product Type
15.3.12.2. Market Revenue and Volume Forecast, by Drug Type
15.3.12.3. Market Revenue and Volume Forecast, by Formulation Type
15.3.12.4. Market Revenue and Volume Forecast, by Application Type
15.3.12.5. Market Revenue and Volume Forecast, by Operation Mode
15.3.12.6. Market Revenue and Volume Forecast, by Scale of Operation
15.3.12.7. Market Revenue and Volume Forecast, by End-User
15.3.12.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.4. MEA
15.4.1. Market Revenue and Volume Forecast, by Product Type
15.4.2. Market Revenue and Volume Forecast, by Drug Type
15.4.3. Market Revenue and Volume Forecast, by Formulation Type
15.4.4. Market Revenue and Volume Forecast, by Application Type
15.4.5. Market Revenue and Volume Forecast, by Operation Mode
15.4.6. Market Revenue and Volume Forecast, by Scale of Operation
15.4.7. Market Revenue and Volume Forecast, by End-User
15.4.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.4.9. GCC
15.4.9.1. Market Revenue and Volume Forecast, by Product Type
15.4.9.2. Market Revenue and Volume Forecast, by Drug Type
15.4.9.3. Market Revenue and Volume Forecast, by Formulation Type
15.4.9.4. Market Revenue and Volume Forecast, by Application Type
15.4.9.5. Market Revenue and Volume Forecast, by Operation Mode
15.4.9.6. Market Revenue and Volume Forecast, by Scale of Operation
15.4.9.7. Market Revenue and Volume Forecast, by End-User
15.4.9.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.4.10. North Africa
15.4.10.1. Market Revenue and Volume Forecast, by Product Type
15.4.10.2. Market Revenue and Volume Forecast, by Drug Type
15.4.10.3. Market Revenue and Volume Forecast, by Formulation Type
15.4.10.4. Market Revenue and Volume Forecast, by Application Type
15.4.10.5. Market Revenue and Volume Forecast, by Operation Mode
15.4.10.6. Market Revenue and Volume Forecast, by Scale of Operation
15.4.10.7. Market Revenue and Volume Forecast, by End-User
15.4.10.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.4.11. South Africa
15.4.11.1. Market Revenue and Volume Forecast, by Product Type
15.4.11.2. Market Revenue and Volume Forecast, by Drug Type
15.4.11.3. Market Revenue and Volume Forecast, by Formulation Type
15.4.11.4. Market Revenue and Volume Forecast, by Application Type
15.4.11.5. Market Revenue and Volume Forecast, by Operation Mode
15.4.11.6. Market Revenue and Volume Forecast, by Scale of Operation
15.4.11.7. Market Revenue and Volume Forecast, by End-User
15.4.11.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.4.12. Rest of MEA
15.4.12.1. Market Revenue and Volume Forecast, by Product Type
15.4.12.2. Market Revenue and Volume Forecast, by Drug Type
15.4.12.3. Market Revenue and Volume Forecast, by Formulation Type
15.4.12.4. Market Revenue and Volume Forecast, by Application Type
15.4.12.5. Market Revenue and Volume Forecast, by Operation Mode
15.4.12.6. Market Revenue and Volume Forecast, by Scale of Operation
15.4.12.7. Market Revenue and Volume Forecast, by End-User
15.4.12.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.5. Latin America
15.5.1. Market Revenue and Volume Forecast, by Product Type
15.5.2. Market Revenue and Volume Forecast, by Drug Type
15.5.3. Market Revenue and Volume Forecast, by Formulation Type
15.5.4. Market Revenue and Volume Forecast, by Application Type
15.5.5. Market Revenue and Volume Forecast, by Operation Mode
15.5.6. Market Revenue and Volume Forecast, by Scale of Operation
15.5.7. Market Revenue and Volume Forecast, by End-User
15.5.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.5.9. Brazil
15.5.9.1. Market Revenue and Volume Forecast, by Product Type
15.5.9.2. Market Revenue and Volume Forecast, by Drug Type
15.5.9.3. Market Revenue and Volume Forecast, by Formulation Type
15.5.9.4. Market Revenue and Volume Forecast, by Application Type
15.5.9.5. Market Revenue and Volume Forecast, by Operation Mode
15.5.9.6. Market Revenue and Volume Forecast, by Scale of Operation
15.5.9.7. Market Revenue and Volume Forecast, by End-User
15.5.9.8. Market Revenue and Volume Forecast, by Technique/Technology Used
15.5.10. Rest of LATAM
15.5.10.1. Market Revenue and Volume Forecast, by Product Type
15.5.10.2. Market Revenue and Volume Forecast, by Drug Type
15.5.10.3. Market Revenue and Volume Forecast, by Formulation Type
15.5.10.4. Market Revenue and Volume Forecast, by Application Type
15.5.10.5. Market Revenue and Volume Forecast, by Operation Mode
15.5.10.6. Market Revenue and Volume Forecast, by Scale of Operation
15.5.10.7. Market Revenue and Volume Forecast, by End-User
15.5.10.8. Market Revenue and Volume Forecast, by Technique/Technology Used
16.1. Anhydro, Inc.
16.1.1. Company Overview
16.1.2. Product Offerings
16.1.3. Financial Performance
16.1.4. Recent Initiatives
16.2. Hosokawa Micron Ltd
16.2.1. Company Overview
16.2.2. Product Offerings
16.2.3. Financial Performance
16.2.4. Recent Initiatives
16.3. B. Bohle Maschinen + Verfahren GmbH
16.3.1. Company Overview
16.3.2. Product Offerings
16.3.3. Financial Performance
16.3.4. Recent Initiatives
16.4. Micron Power Systems
16.4.1. Company Overview
16.4.2. Product Offerings
16.4.3. Financial Performance
16.4.4. Recent Initiatives
16.5. JEL Drying Solutions (A/S)
16.5.1. Company Overview
16.5.2. Product Offerings
16.5.3. Financial Performance
16.5.4. Recent Initiatives
16.6. Armfield Ltd
16.6.1. Company Overview
16.6.2. Product Offerings
16.6.3. Financial Performance
16.6.4. Recent Initiatives
16.7. Buchi Labortechnik AG
16.7.1. Company Overview
16.7.2. Product Offerings
16.7.3. Financial Performance
16.7.4. Recent Initiatives
16.8. NiTech Solutions LLC
16.8.1. Company Overview
16.8.2. Product Offerings
16.8.3. Financial Performance
16.8.4. Recent Initiatives
16.9. Novatech International, Inc
16.9.1. Company Overview
16.9.2. Product Offerings
16.9.3. Financial Performance
16.9.4. Recent Initiatives
16.10. Innovative Drying Solutions, LLC.
16.10.1. Company Overview
16.10.2. Product Offerings
16.10.3. Financial Performance
16.10.4. Recent Initiatives
16.7. Primary Research
16.7. Secondary Research
16.7. Assumptions
18.1. About Us
18.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description